Higher Incidence of Unruptured Intracranial Aneurysms among Black and Hispanic Women on Screening MRA in Large Urban Populations

References

1. 1.↵
   1. Brown RD,
   2. Broderick JP

   . Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol 2014;13:393–404 doi:10.1016/S1474-4422(14)70015-8 pmid:24646873

   CrossRefPubMed
2. 2.↵
   1. Keedy A

   . An overview of intracranial aneurysms. Mcgill J Med 2006;9:141–46 pmid:18523626

   PubMed
3. 3.↵
   1. Nieuwkamp DJ,
   2. Setz LE,
   3. Algra A, et al

   . Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009;8:635–42 doi:10.1016/S1474-4422(09)70126-7 pmid:19501022

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Etminan N,
   2. de Sousa DA,
   3. Tiseo C, et al

   . European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms. Eur Stroke J 2022;7:V doi:10.1177/23969873221099736 pmid:36082246

   CrossRefPubMed
5. 5.↵
   1. Morel S,
   2. Hostettler IC,
   3. Spinner GR, et al

   ; The neurIST Project. Intracranial aneurysm classifier using phenotypic factors: an international pooled analysis. J Pers Med 2022;12:1410 doi:10.3390/jpm12091410 pmid:36143196

   CrossRefPubMed
6. 6.↵
   1. Thompson BG,
   2. Brown RD,
   3. Amin-Hanjani S, et al

   ; American Stroke Association. Guidelines for the management of patients with unruptured intracranial aneurysms. Stroke 2015;46:2368–400 doi:10.1161/STR.0000000000000070 pmid:26089327

   Abstract/FREE Full Text
7. 7.↵
   1. Chalouhi N,
   2. Chitale R,
   3. Jabbour P, et al

   . The case for family screening for intracranial aneurysms. Neurosurg Focus 2011;31:E8 doi:10.3171/2011.9.FOCUS11210 pmid:22133176

   CrossRefPubMed
8. 8.↵
   1. Sanchis IM,
   2. Shukoor S,
   3. Irazabal MV, et al

   . Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2019;14:1151–60 doi:10.2215/CJN.14691218 pmid:31362991

   Abstract/FREE Full Text
9. 9.↵
   1. Backes D,
   2. Rinkel GJ,
   3. Laban KG, et al

   . Patient- and aneurysm-specific risk factors for intracranial aneurysm growth. Stroke 2016;47:951–57 doi:10.1161/STROKEAHA.115.012162 pmid:26906920

   Abstract/FREE Full Text
10. 10.↵
    R Core Team. The R Project for Statistical Computing. R Foundation for Statistical Computing. https://www.R-project.org. Accessed June 29, 2022
11. 11.↵
    1. Brinjikji W,
    2. Zhu YQ,
    3. Lanzino G, et al

    . Risk factors for growth of intracranial aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2016;37:615–20 doi:10.3174/ajnr.A4575 pmid:26611992

    Abstract/FREE Full Text
12. 12.↵
    1. Greving JP,
    2. Wermer MJ,
    3. Brown RD, et al

    . Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014;13:59–66 doi:10.1016/S1474-4422(13)70263-1 pmid:24290159

    CrossRefPubMed
13. 13.↵
    1. Rosi Junior J,
    2. Gomes dos Santos A,
    3. da Silva SA, et al

    . Multiple and mirror intracranial aneurysms: study of prevalence and associated risk factors. Br J Neurosurg 2021;35:780–84 doi:10.1080/02688697.2020.1817849 pmid:33164602

    CrossRefPubMed
14. 14.↵
    1. Fuentes AM,
    2. Stone McGuire L,
    3. Amin-Hanjani S

    . Sex differences in cerebral aneurysms and subarachnoid hemorrhage. Stroke 2022;53:624–33 doi:10.1161/STROKEAHA.121.037147 pmid:34983239

    CrossRefPubMed
15. 15.↵
    1. Zuurbier CC,
    2. Molenberg R,
    3. Mensing LA, et al

    . Sex difference and rupture rate of intracranial aneurysms: an individual patient data meta-analysis. Stroke 2022;53:362–69 doi:10.1161/STROKEAHA.121.035187 pmid:34983236

    CrossRefPubMed
16. 16.↵
    1. Garcia RM,
    2. Yoon S,
    3. Potts MB, et al

    . Investigating the role of ethnicity and race in patients undergoing treatment for intracerebral aneurysms between 2008 and 2013 from a national database. World Neurosurg 2016;96:230–36 doi:10.1016/j.wneu.2016.08.114 pmid:27609451

    CrossRefPubMed
17. 17.↵
    1. Rinaldo L,
    2. Rabinstein AA,
    3. Cloft HJ, et al

    . Racial and economic disparities in the access to treatment of unruptured intracranial aneurysms are persistent problems. J Neurointerv Surg 2019;11:833–36 doi:10.1136/neurintsurg-2018-014626 pmid:30674633

    Abstract/FREE Full Text
18. 18.↵
    1. Brinjikji W,
    2. Rabinstein AA,
    3. Lanzino G, et al

    . Racial and ethnic disparities in the treatment of unruptured intracranial aneurysms. Stroke 2012;43:3200–06 doi:10.1161/STROKEAHA.112.671214 pmid:23132781

    Abstract/FREE Full Text
19. 19.↵
    1. Karhunen V,
    2. Bakker MK,
    3. Ruigrok YM, et al

    . Modifiable risk factors for intracranial aneurysm and aneurysmal subarachnoid hemorrhage: a Mendelian randomization study. J Am Heart Assoc 2021;10:e022277 doi:10.1161/JAHA.121.022277 pmid:34729997

    CrossRefPubMed
20. 20.↵
    1. Kotikoski S,
    2. Kurtelius A,
    3. Nurmonen HJ, et al

    . Pre-eclampsia, gestational diabetes and hypertensive disorders in patients with intracranial aneurysms: a case–control study. Eur J Neurol 2022;29:199–207 doi:10.1111/ene.15125 pmid:34570429

    CrossRefPubMed
21. 21.↵
    1. Sundström J,
    2. Söderholm M,
    3. Söderberg S, et al

    . Risk factors for subarachnoid haemorrhage: a nationwide cohort of 950 000 adults. Int J Epidemiol 2019;48:2018–25 doi:10.1093/ije/dyz163 pmid:31363756

    CrossRefPubMed
22. 22.↵
    1. Kotikoski S,
    2. Huttunen J,
    3. Huttunen TJ, et al

    . Secondary hypertension in patients with saccular intracranial aneurysm disease: a population-based study. PLoS One 2018;13:e0206432 doi:10.1371/journal.pone.0206432 pmid:30379949

    CrossRefPubMed
23. 23.↵
    1. Feigin VL,
    2. Rinkel GJ,
    3. Lawes CM, et al

    . Risk factors for subarachnoid hemorrhage. Stroke 2005;36:2773–80 doi:10.1161/01.STR.0000190838.02954.e8 pmid:16282541

    Abstract/FREE Full Text
24. 24.↵
    1. Rinkel GJ,
    2. Ruigrok YM

    . Preventive screening for intracranial aneurysms. Int J Stroke 2022;17:30–36 doi:10.1177/17474930211024584 pmid:34042530

    CrossRefPubMed
25. 25.↵
    1. Zhou Z,
    2. Xu Y,
    3. Delcourt C, et al

    . Is regular screening for intracranial aneurysm necessary in patients with autosomal dominant polycystic kidney disease? A systematic review and meta-analysis. Cerebrovasc Dis 2017;44:75–82 doi:10.1159/000476073 pmid:28502970

    CrossRefPubMed
26. 26.↵
    1. Chen Y,
    2. Huang M,
    3. Xuan Y, et al

    . Association between lipid levels and risk for different types of aneurysms: a Mendelian randomization study. J PersMed 2021;11:1171 doi:10.3390/jpm11111171 pmid:34834523

    CrossRefPubMed